文献速递心力衰竭与心肌病

慢性心衰患者血清钾水平与死亡率的相关性

Associations of serum potassium levels with mortality in chronic heart failure patients.
PubMed 文献 · Eur Heart J · 2017-01-01

该研究基于丹麦国家登记数据,纳入19 549例在启动袢利尿剂及ACEI/ARB治疗后至少90天内测量过血钾的慢性心衰患者,按八个预设钾水平分层分析90天全因死亡率。以4.2-4.4 mmol/L为参照,结果显示钾水平在3.5-4.1 mmol/L和4.8-5.0 mmol/L范围内以及低于3.5 mmol/L或高于5.0 mmol/L均与全因死亡风险显著增加相关。

要点

  • 慢性心衰患者血钾4.2-4.4 mmol/L为最低死亡风险参照水平。
  • 血钾3.5-4.1 mmol/L和4.8-5.0 mmol/L范围内死亡风险已显著升高。
  • 血钾低于3.5 mmol/L或高于5.0 mmol/L与死亡风险进一步增加相关。

核心结论

  • 慢性心衰患者血钾处于正常范围低端(3.5-4.1 mmol/L)和高端(4.8-5.0 mmol/L)即与短期全因死亡风险显著增加相关。
  • 血钾低于3.5 mmol/L或高于5.0 mmol/L同样与死亡率增加相关。

研究设计与样本

  • 基于丹麦国家登记数据的回顾性队列研究,纳入19 549例慢性心衰患者,均在启动袢利尿剂及ACEI/ARB治疗后至少90天内测量过血钾。
  • 按八个预设钾水平分层(2.8-3.4、3.5-3.8、3.9-4.1、4.2-4.4、4.5-4.7、4.8-5.0、5.1-5.5、5.6-7.4 mmol/L),随访90天,采用多变量调整Cox比例风险模型评估全因死亡风险。

主要发现

  • 90天时八层死亡率分别为14.4%、8.0%、6.3%、5.0%、5.8%、7.9%、10.3%和21.1%。

临床怎么用

  • 对慢性心衰患者应关注血钾水平,即使处于正常范围的低端或高端也可能提示短期死亡风险增加。
  • 血钾管理目标可参考4.2-4.4 mmol/L附近,避免低于3.5 mmol/L或高于5.0 mmol/L。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Medication prescribed to patients suffering from chronic heart failure carries an increased risk of impaired potassium homeostasis. We examined the relation between different levels of serum potassium and mortality among patients with chronic heart failure. METHODS AND RESULTS: From Danish National registries, we identified 19 549 patients with a chronic heart failure diagnosis who had a measurement of potassium within minimum 90 days after initiated medical treatment with loop diuretics and angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers. All-cause mortality was examined according to eight predefined potassium levels: 2.8-3.4 mmol/L, 3.5-3.8 mmol/L, 3.9-4.1 mmol/L, 4.2-4.4 mmol/L, 4.5-4.7 mmol/L, 4.8-5.0 mmol/L, 5.1-5.5 mmol/L, and 5.6-7.4 mmol/L. Follow-up was 90 days from potassium measurement. We estimated the risk of all-cause mortality using multivariable adjusted Cox proportional hazard model, with normal serum potassium level at 4.2-4.4 mmol/L as reference. After 90 days, the mortality in the eight strata was 14.4, 8.0, 6.3, 5.0, 5.8, 7.9, 10.3, and 21.1% respectively. In multivariable adjusted analysis, patients with potassium levels of 2.8-3.4 mmol/L [hazard ratio (HR): 3.16; confidence interval (CI): 2.43-4.11], 3.5-3.8 mmol/L (HR: 1.62; CI: 1.31-1.99), 3.9-4.1 mmol/L (HR: 1.29; CI: 1.08-1.55), 4.8-5.0 mmol/L (HR: 1.34; CI: 1.10-1.63), 5.1-5.5 mmol/L (HR: 1.60; CI: 1.29-1.97), and 5.6-7.4 mmol/L (HR: 3.31; CI: 2.61-4.20) had an increased risk of all-cause mortality. CONCLUSION: Levels within the lower and upper levels of the normal serum potassium range (3.5-4.1 mmol/L and 4.8-5.0 mmol/L, respectively) were associated with a significant increased short-term risk of death in chronic heart failure patients. Likewise, potassium below 3.5 mmol/L and above 5.0 mmol/L was also associated with increased mortality.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Aldahl M, Jensen AC, Davidsen L, et al. Associations of serum potassium levels with mortality in chronic heart failure patients. Eur Heart J. 2017. PMID: 29019614. doi:10.1093/eurheartj/ehx460

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。